We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$2.93B
AUM Growth
-$232M
Cap. Flow
-$337M
Cap. Flow %
-11.5%
Top 10 Hldgs %
37.72%
Holding
51
New
–
Increased
2
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$37.8M
2
ABT icon
Abbott
ABT
+$34.5M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$97.2M
2
DD icon
DuPont de Nemours
DD
+$18.7M
3
SLB icon
SLB Ltd
SLB
+$17.3M
4
PPL
PPL Corp
PPL
+$14.7M
5
DIS icon
Walt Disney
DIS
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Industrials 14.08%
3 Communication Services 12.63%
4 Energy 12.32%
5 Utilities 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$223B
$77.2M 2.63%
654,353
-66,667
-9% -$7.85M
AMGN icon
27
Amgen
AMGN
$225B
$77.2M 2.63%
652,295
+326,197
+100% +$37.8M
ABT icon
28
Abbott
ABT
$192B
$76.7M 2.61%
1,875,695
+877,436
+88% +$34.5M
QCOM icon
29
Qualcomm
QCOM
$171B
$75.3M 2.56%
950,246
-112,991
-11% -$8.98M
ORCL icon
30
Oracle
ORCL
$442B
$74.5M 2.54%
1,839,224
-246,444
-12% -$10.1M
MDLZ icon
31
Mondelez International
MDLZ
$79.4B
$8.52M 0.29%
226,650
-64,100
-22% -$2.34M
TE
32
DELISTED
TECO ENERGY INC
TE
$8.14M 0.28%
440,700
-125,400
-22% -$2.2M
APA icon
33
APA Corp
APA
$14B
$3.81M 0.13%
37,850
-24,900
-40% -$2.26M
FE icon
34
FirstEnergy
FE
$27.2B
$3.29M 0.11%
94,900
-350
-0.4% -$11.8K
UNP icon
35
Union Pacific
UNP
$174B
$3.08M 0.11%
30,900
– –
ADP icon
36
Automatic Data Processing
ADP
$107B
$2.35M 0.08%
33,714
-24,945
-43% -$1.7M
A icon
37
Agilent Technologies
A
$41.9B
$2.23M 0.08%
54,173
– –
BMY icon
38
Bristol-Myers Squibb
BMY
$130B
$1.44M 0.05%
29,700
– –
CL icon
39
Colgate-Palmolive
CL
$73.6B
$1.19M 0.04%
17,400
– –
ZBH icon
40
Zimmer Biomet
ZBH
$18.7B
$1.08M 0.04%
10,712
-14,729
-58% -$1.44M
GILD icon
41
Gilead Sciences
GILD
$168B
$1.04M 0.04%
12,600
-17,700
-58% -$1.38M
UNH icon
42
UnitedHealth
UNH
$364B
$1.04M 0.04%
12,700
– –
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.09T
$949K 0.03%
7,500
– –
PEP icon
44
PepsiCo
PEP
$189B
$652K 0.02%
7,300
– –
PG icon
45
Procter & Gamble
PG
$335B
$593K 0.02%
7,550
– –
ABBV icon
46
AbbVie
ABBV
$440B
$480K 0.02%
8,500
– –
NEE icon
47
NextEra Energy
NEE
$179B
$466K 0.02%
18,200
-2,400
-12% -$58.4K
KSU
48
DELISTED
Kansas City Southern
KSU
$344K 0.01%
3,200
– –
HON icon
49
Honeywell
HON
$74.6B
$279K 0.01%
3,339
– –
BDX icon
50
Becton Dickinson
BDX
$50B
– –
-6,458
Closed -$738K
1
2
3

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Stralem & Co held 51 positions worth $2.93B, down 7.3% from $3.17B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stralem & Co withdrew a net $337M in Q2 2014, closing 2 positions and reducing 36 holdings. Its most notable exit was IBM, an estimated $97.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Stralem & Co added an estimated $37.8M to Amgen.

  • Stralem & Co added most to Amgen in Q2 2014, an estimated $37.8M increase.
  • Stralem & Co's biggest Q2 2014 reduction was DuPont de Nemours, cutting an estimated $18.7M.
  • Stralem & Co fully exited IBM in Q2 2014, selling an estimated $97.2M.
  • Stralem & Co's ten largest holdings make up 38% of its $2.93B portfolio in Q2 2014.
  • Stralem & Co opened 0 new positions and closed 2 in Q2 2014.
  • Stralem & Co's portfolio value fell 7.3% quarter-over-quarter to $2.93B.

Based on Stralem & Co's 13F filing for Q2 2014, filed 16 Jul 2014.